Breaking News
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Dendreon Swings To Profit In Q4 - Quick Facts

RELATED NEWS
Trade DNDN now with 
2/27/2012 8:50 AM ET

Dendreon Corp. (DNDN: Quote) reported fourth-quarter profit of $38.1 million or $0.26 per share versus loss of $91.83 million or $0.64 per share a year earlier.

Non-GAAP net income per share-basic was $0.45 versus loss per share-basic of $0.50 last year.

On average, 21 analysts polled by Thomson Reuters expected the company to report loss of $0.23 per share. Analysts' estimates typically exclude special items.

Total revenue surged to $202.15 million from $25 million a year ago. Analysts estimated revenues of $120.80 million.

Product revenue for the quarter was $77 million compared to $25 million in the prior-year quarter.

Click here to receive FREE breaking news email alerts for Dendreon Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks are turning in a lackluster performance in morning trading on Monday after showing a strong move to the upside last week. The major averages have been unable to sustain any significant moves, bouncing back and forth across the unchanged line. Leading U.S. economic indicators showed continued improvement in the month of March, according to a report released by the Conference Board on Monday, with the leading economic index rising by slightly more than expected. The Conference Board said its leading economic index rose by 0.8 percent in March after climbing by 0.5 percent in February. Healthcare products maker Kimberly-Clark Corp. (KMB) said that its first-quarter net income attributable to the company rose to $538 million from the prior year's $531 million, with earnings per share improving to $1.41 from $1.36 last year. Adjusted earnings for the quarter were $1.48 per share,...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.